MM+M (@MMMnews) on X (Twitter)

This page is public and can appear in search results. The audience and topic lines below are AI-inferred and may be wrong.
Claim this page → · Correct it, take it out of search, or remove it →

MM+M is a creator on X (Twitter) in the 10K–20K follower range, publishing for Pharmaceutical and healthcare marketing professionals, primarily agency executives, pharma brand marketers, and industry analysts focused on medical advertising and trends, based in United States. Profile last checked 2026-07-05.

Observed facts (from the public profile):

Profile bio

MM+M: the most objective, relevant, and timely source of news, analysis, and trends in pharmaceutical and healthcare marketing

What this creator posts about, and who reads it (AI-inferred)

Recurring topics: Medical marketing industry news and analysis, Agency rankings and revenue data, AI integration challenges for agencies, Pharma regulatory and political developments, Industry events and awards

Audience: Pharmaceutical and healthcare marketing professionals, primarily agency executives, pharma brand marketers, and industry analysts focused on medical advertising and trends

Provenance: inferred by AI from public content, not stated by the creator — confidence 0.40 · read from 6 recent posts · updated 77 days ago.

Audience read from this creator’s own recent posts, not from platform-declared categories. It is our reading, and it can be wrong.

Recent content samples (what the inference above was drawn from)

Walt Geer leaves VML: Why he’s taking a leap of faith https://t.co/dH9jqMneth

The biggest night in the medical marketing industry is approaching soon. Did you secure your tickets to be a part of it? Join us for our diamond anniversary at the MM+M Awards on October 1 in NYC! Get your tickets here…

The 2026 Agency 100 spotlights nearly 150 companies! Explore revenue data, top agency profiles, and our new MM+M Intelligence chatbot. Check it out: https://t.co/9TcIN89PLh https://t.co/f5hFALNi3f

Five things for pharma marketers to know for Thursday, August 6, 2026 https://t.co/PoWQhYKEVw #MedicalMarketing #Pharma

See the original post on X (Twitter)

Where this creator sits among comparable accounts

Compared with the 1,257 accounts in the same group (x · koc · software):

This is a position, not a verdict. A percentile says where this account falls among comparable accounts on signals we can measure — it does not say this creator is a better fit for your campaign. We ran a blind benchmark and measured no reliable advantage in selection quality, and do not claim one.

Koinon Link indexes X (Twitter) creators in Software with grade, authenticity and contactability broken down — see the X (Twitter) × Software breakdown, or the Creator Index Report for the whole index.

Other Software creators on X (Twitter)

• Fiz (@MRB_AI24) — AI tools lists
• MAPEMA (@Mapemaofweb3) — Free productivity tools
• Korn🐬TermMax (@MasterX093) — Fixed-rate lending in DeFi
• Alexander (@Mdkhurshed76417) — AI research tools
• Meeee (@MeeMoses83411) — AI agent integrations
• Michel Lieben (@MichLieben) — AI and code automation for paid ads
• MinionLab (@MinionLabAI) — Open-weight AI models
• Ash (@Must_be_Ash) — AI agents and tool payments

Creators next to this one by follower tier in the same slice. Each link opens that creator’s public profile — what they post about and who reads it, with no contact details.

This page lists public profile information only. It carries no contact details and no authenticity score. If you are MM+M and want this page removed, request removal.

Machine-readable representations

Structured twins of this page for AI and agents — every inferred field carries its source, confidence and freshness.

• /kol/x/MMMnews.json
• /kol/x/MMMnews.md

AI retrieval activity

What AI systems have actually done with this page. The two kinds are counted separately: being indexed is not the same as being used.